New pill 83-0060 passes first safety check in healthy volunteers
NCT ID NCT06402136
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested the safety and tolerability of an experimental oral drug called 83-0060 in 57 healthy adults aged 18 to 65. Participants received either the drug or a placebo, and researchers monitored for side effects and how the drug moved through the body. The goal was not to treat any disease, but to gather essential safety data before future trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS ONLY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Scientia Clinical Research
Sydney, Greater Sydney Area, NSW 2031, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.